Advertisements


Lineage Cell Therapeutics conducts sale of shares in OncoCyte

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 11th, 2019

Global Blood Therapeutics stock up 40% after FDA agrees to accelerated approval pathway for sickle cell disease drug

Shares of Global Blood Therapeutics Inc. shot up 40% Monday morn.....»»

Category: topSource: marketwatchDec 3rd, 2018

Global Blood"s Sickle Cell Disease Drug Snags Accelerated FDA Approval Pathway

Global Blood Therapeutics Inc (NASDAQ: GBT) shares are trading at a nearly three-month high, with a FDA event being the catalyst. Latest Ratings for GBT DateF.....»»

Category: blogSource: benzingaDec 3rd, 2018

How Global Blood Therapeutics Is Capitalizing on Its Sickle Cell Disease Approval

GBT shares dipped on Friday after the company announced that it would be conducting a secondary offering. This offering comes on the heels of a key FDA approval......»»

Category: blogSource: 247wallstDec 7th, 2018

Why G1 Therapeutics Got Hammered 42.6% Today

What happened G1 Therapeutics NASDAQ GTHX reported phase 2 trial data on its lead drug candidate that failed to inspire investor optimism and shares crashed 42 6 on Thursday So what The company is developing trilaciclib a cell preserving drug it hopes.....»»

Category: futuresSource: nasdaqDec 20th, 2018

Liberty Global backs Sunrise capital hike with 500 million sfr offer

Liberty Global has offered to buy up to 500 million Swiss francs ($502.11 million) in newly created Sunrise Communications shares - a move aimed at rescuing the 6.3 billion franc sale of its Swiss business......»»

Category: topSource: reuters6 hr. 25 min. ago

Protagonist Therapeutics (PTGX) Shares Cross Below 200 DMA

Market News Video.....»»

Category: topSource: redinewsOct 11th, 2019

Mid-Day Market Update: Crude Oil Up 1.5%; Aclaris Therapeutics Shares Jump

Midway through trading Friday, the Dow traded up 1.53% to 26901.25 while the NASDAQ rose 1.82% to 8095.51. The S&P also rose, gaining 1.59% to 2,984.85. Leading and Lagging Sectors Material shares climbed 2.3% on Friday. Meanwhile, top gaine.....»»

Category: earningsSource: benzingaOct 11th, 2019

Mid-Day Market Update: Crude Oil Up 1.5%; Aclaris Therapeutics Shares Jump

Midway through trading Friday, the Dow traded up 1.53% to 26901.25 while the NASDAQ rose 1.82% to 8095.51. The S&P also rose, gaining 1.59% to 2,984.85. read more.....»»

Category: blogSource: benzingaOct 11th, 2019

Viveve Medical stock plunges toward record low after filing to sell more shares

Shave of Viveve Medical Inc. sank 9.7% toward a record low in premarket trading Friday, after the provider of health products and women's health services filed for the sale of.....»»

Category: topSource: marketwatchOct 11th, 2019

Fastenal"s stock surges as profit, sales rise above expectations

Shares of Fastenal Co. surged 5.6% in premarket trading Friday after the maker of fasteners, tools and manufacturing supplies reported third-quarter profit and sale.....»»

Category: topSource: marketwatchOct 11th, 2019

Large Amounts Of Insider Trading In Aprea Therapeutics Following IPO

Aprea Therapeutics Inc (NASDAQ: APRE) shares cooled a bit Tuesday after getting off to a hot start on the market following an Oct. 3 IPO. read more.....»»

Category: blogSource: benzingaOct 8th, 2019

Global Blood Therapeutics shares rise amid analyst, investor day presentation

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 8th, 2019

Axsome Therapeutics (AXSM) Shares Cross Below 200 DMA

Market News Video.....»»

Category: topSource: redinewsOct 8th, 2019

Asure Software"s stock soars on heavy volume after $120 million deal to sell workspace management business

Shares of Asure Software Inc. soared 29% in active premarket trading Tuesday, after the cloud platform company announced the sale of its workspace management business in an asset and equity deal valued at $120 million. Tra.....»»

Category: topSource: marketwatchOct 8th, 2019

Nektar Therapeutics shares slide 6.3% premarket after Goldman downgrades to sell from buy

Nektar Therapeutics shares slid 6.3% in premarket trade Tuesday, after Goldman Sachs downgraded the stock to sell from buy and said the stock will likely flounder in the near term due to quality issues and a nar.....»»

Category: topSource: marketwatchOct 8th, 2019

Mid-Day Market Update: U.S. Stocks Turn Positive; Akcea Therapeutics Shares Jump

Midway through trading Monday, the Dow traded up 0.08% to 26594.58 while the NAS.....»»

Category: earningsSource: benzingaOct 7th, 2019

Mid-Day Market Update: Dow Rises Over 200 Points; Ovid Therapeutics Shares Plunge

Midway through trading Friday, the Dow traded up 0.85% to 26424.61 while the NASDAQ rose 0.91% to 7,944.17. The S&P also rose, gaining 0.87% to 2,935.92. Leading and Lagging Sectors Information technology .....»»

Category: earningsSource: benzingaOct 4th, 2019

Phoenix New Media announces update on proposed sale of 34% of Particle shares

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 4th, 2019

Mirati Therapeutics (MRTX) Shares Cross Below 200 DMA

Market News Video.....»»

Category: topSource: redinewsOct 1st, 2019

HBT Financial sets IPO terms to raise up to $158 million, be valued at $500 million

HBT Financial set terms of its initial public offering, in which the Illinois-based bank is looking to raise up to $157.7 million, and be valued at about $500.2 million. The bank if offering 8.3 million shares for sale in the IPO, w.....»»

Category: topSource: marketwatchOct 1st, 2019